
Evotec inks license agreement with J&J; Oncolytic virus biotech prices $15M IPO
Drug discovery and development player Evotec entered another licensing deal with Big Pharma — this time with J&J’s Janssen. The companies put out word that they entered into a strategic collaboration and license agreement with each other […]